Vashti C. Bryant, Ph.D.

2011 University of Texas Medical Branch, Galveston, TX 
Molecular Biology, Pharmaceutical Chemistry
"Vashti Bryant"
Mean distance: (not calculated yet)


Sign in to add mentor
Amarnath Natarajan grad student 2011 UTMB
 (Synthesis and Evaluation of Natural Product-Derived Small Molecules as NF-kappaB Inhibitors.)
Amarnath (Amar) Natarajan grad student 2006-2011 UTMB
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Radhakrishnan P, Bryant VC, Blowers EC, et al. (2013) Targeting the NF-κB and mTOR pathways with a quinoxaline urea analog that inhibits IKKβ for pancreas cancer therapy. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 19: 2025-35
Rajule R, Bryant VC, Lopez H, et al. (2012) Perturbing pro-survival proteins using quinoxaline derivatives: a structure-activity relationship study. Bioorganic & Medicinal Chemistry. 20: 2227-34
Bryant VC, Kishore Kumar GD, Nyong AM, et al. (2012) Synthesis and evaluation of macrocyclic diarylether heptanoid natural products and their analogs. Bioorganic & Medicinal Chemistry Letters. 22: 245-8
Chen Q, Bryant VC, Lopez H, et al. (2011) 2,3-Substituted quinoxalin-6-amine analogs as antiproliferatives: a structure-activity relationship study. Bioorganic & Medicinal Chemistry Letters. 21: 1929-32
Bryant VC, Radhakrishnan P, Hollingsworth MA, et al. (2011) Abstract LB-206: A novel scaffold that targets the IKK complex Cancer Research. 71
See more...